SpringerLink
Log in

A healthy outcome of a pregnant woman with drug-resistant juvenile myoclonic epilepsy treated with brivaracetam

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Subramonian A, Farrah K (2020) Brivaracetam versus levetiracetam for epilepsy: a review of comparative clinical safety. Canadian Agency for Drugs and Technologies in Health, pp 1–35

  2. Grande-Martín A, Sopelana-Garay D, Pardal-Fernández JM et al (2018) Exceptional response to brivaracetam in a patient with refractory idiopathic generalized epilepsy and absence seizures. Epileptic Disord 20:60–64. https://doi.org/10.1684/EPD.2017.0939

    Article  Google Scholar 

  3. Strzelczyk A, Kay L, Bauer S et al (2018) Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus. Epilepsia 59:1549–1556. https://doi.org/10.1111/epi.14476

    Article  CAS  Google Scholar 

  4. Hirsch E, French J, Scheffer IE et al (2022) ILAE definition of the idiopathic generalized epilepsy syndromes: position statement by the ILAE Task Force on nosology and definitions. Epilepsia 63:1475–1499. https://doi.org/10.1111/epi.17236

    Article  Google Scholar 

  5. Kwan P, Arzimanoglou A, Berg AT et al (2009) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE commission on therapeutic strategies. Epilepsia 51:1069–1077. https://doi.org/10.1111/j.1528-1167.2009.02397.x

    Article  CAS  Google Scholar 

  6. Fonseca E, Guzmán L, Quintana M et al (2020) Efficacy, retention, and safety of brivaracetam in adult patients with genetic generalized epilepsy. Epilepsy Behav 102:106657. https://doi.org/10.1016/j.yebeh.2019.106657

    Article  Google Scholar 

  7. Paolini SL, Pilato M, Rajasekaran V et al (2020) Outcomes in three cases after brivaracetam treatment during pregnancy. Acta Neurol Scand 141:438–441. https://doi.org/10.1111/ane.13222

    Article  CAS  Google Scholar 

  8. Landmark CJ, Rektorli L, Burns ML et al (2021) Pharmacokinetic data on brivaracetam, lacosamide and perampanel during pregnancy and lactation. Epileptic Disord 23:426–431. https://doi.org/10.1684/epd.2021.1273

    Article  Google Scholar 

Download references

Acknowledgements

I thank the patient for allowing me to publish her case. I also thank Valentina Forget for correcting the style of the manuscript.

Author information

Authors and Affiliations

  1. Unit of Clinical Neurology, School of Medicine, Universidad Nacional de Colombia, Ciudad Universitaria carrera 30 # 45-03, 111321, Bogotá, Colombia

    Cristian Eduardo Navarro

  2. Grupo de Investigación en Neurología de la Universidad Nacional de Colombia—NeuroUnal, Bogotá, Colombia

    Cristian Eduardo Navarro

  3. Medical Cannabis and Drug-Resistant Epilepsy Program, Clínica Zerenia, Bogotá, Colombia

    Cristian Eduardo Navarro

Authors
  1. Cristian Eduardo Navarro
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

CEN: conceptualization, review of literature, data collection, analysis, writing and editing the manuscript.

Corresponding author

Correspondence to Cristian Eduardo Navarro.

Ethics declarations

Ethical approval

Ethics approval is not required for case reports at our institution.

Consent to participate

The patient gave her informed consent to participate in this study.

Consent for publication

The patient gave her informed consent to publish the case.

Conflict of interest

The author declares no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Navarro, C.E. A healthy outcome of a pregnant woman with drug-resistant juvenile myoclonic epilepsy treated with brivaracetam. Neurol Sci 44, 753–755 (2023). https://doi.org/10.1007/s10072-022-06444-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-022-06444-7

Keywords

Search

Navigation